CitroTech Inc. CITR

Healthcare SIC 2800 - Chemicals & Allied Products NAICS Manufacturing › Chemical Manufacturing derived NYSE

"us," or the "Company") is an environmentally sustainable specialty chemical company focused on fire inhibitor

products serving the wildland fire, residential home protection, and wood products industries across the United States and Canada. Our

fire inhibitor formulations are also sold into the lumber and building materials industry for fire retardant treatment applications. CitroTech

Inc. was originally incorporated under the laws of the State of Nevada on March 14, 1990 and on June 3, 2021 was redomiciled to the State

Last close 2.65 2026-10-23
Market cap $59.8M 2026-06-30 share count
52-week range 2.20 - 10.37

Valuation FY2025 figures against the last close

P/S25.1x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-2.96

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $2.4M$808.4K$520.6K$62.7K$0———
Cost of revenue $1.9M$655.5K$182.7K$56.3K$18.6K$0——
Gross profit $530.7K$152.9K$387.1K$60.8K$20.3K$0——
R&D $198.5K$14.0K$0—————
SG&A $1.6M$498.4K$256.6K$256.7K$3.7K$0——
Total operating expenses $18.9M$6.1M$10.6M$3.0M$58.2K$109.4K$0—
Operating income -$16.5M-$5.3M-$10.1M-$2.9M-$37.9K-$109.4K——
Interest expense $1.5M$257.8K$4.3K$255$1.5K$0——
Pre-tax income -$36.8M-$6.9M-$10.1M-$2.9M-$45.0K-$109.4K$0—
Income tax $0$0$0$0$0$0$0—
Net income -$36.8M-$6.9M-$10.1M-$2.9M-$95.0K-$109.4K$0—
EPS, basic -2.96-0.82-0.10-0.050.000.00——
EPS, diluted -2.96-0.82-0.100.000.000.000.00—
Shares, diluted (wtd. avg.) 12.4M8.4M96.7M62.3M22.9M22.9M——

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $6.3M$775.1K$549.8K$55.4K$5.5K$0$0$0
Receivables $209.0K$317.5K$427.4K$0————
Inventory $620.8K$324.7K$230.2K$114.6K$0———
Total current assets $7.4M$1.6M$1.2M$170.3K$5.5K$0$0—
Property, plant and equipment $630.3K$111.4K$7.3K$4.5K$291.4K$0——
Goodwill —————$53.0K——
Other intangibles $5.3M$3.7M$3.9M$4.2M$33.3K———
Total assets $14.2M$5.5M$5.3M$4.4M$81$0$0—
Accounts payable $316.3K$187.0K$54.6K$87.4K$10.7K$0——
Short-term debt —$96.8K$0—————
Total current liabilities $2.2M$2.2M$1.6M$1.1M$383.1K$9.4K$0—
Total liabilities $2.9M$2.2M$1.7M$1.1M$383.1K$9.4K$0—
Retained earnings -$113.2M-$76.4M-$69.5M-$59.4M-$56.5M-$56.4M-$56.3M—
Total equity $11.3M$3.3M$3.6M$3.3M-$52.9K-$9.4K$0$0

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow -$5.9M-$1.9M-$1.2M-$708.5K-$24.2K$0$0—
Depreciation and amortisation $81.4K$16.1K$1.3K$15.9K$0———
Stock-based compensation $19.1M$3.1M$9.0M$2.1M$0$100.0K$0—
Capital expenditure $194.0K$0$4.0K$5.3K$0———
Investing cash flow -$294.0K$0-$4.0K-$5.3K-$287.1K$0——
Financing cash flow $11.7M$2.2M$1.7M$763.8K$316.8K$0——

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001683168-26-003464.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -40M -30M -20M -10M 0 10M Net income, FY2019: 0 Gross profit, FY2020: 0 Net income, FY2020: -109.4K Revenue, FY2021: 0 Gross profit, FY2021: 20.3K Net income, FY2021: -95K Revenue, FY2022: 62.7K Gross profit, FY2022: 60.8K Net income, FY2022: -2.9M Revenue, FY2023: 520.6K Gross profit, FY2023: 387.1K Net income, FY2023: -10.1M Revenue, FY2024: 808.4K Gross profit, FY2024: 152.9K Net income, FY2024: -6.9M Revenue, FY2025: 2.4M Gross profit, FY2025: 530.7K Net income, FY2025: -36.8M FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — — — $0 $62.7K $520.6K $808.4K $2.4M
Gross profit — — $0 $20.3K $60.8K $387.1K $152.9K $530.7K
Net income — $0 -$109.4K -$95.0K -$2.9M -$10.1M -$6.9M -$36.8M

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
  • Material agreement signed Item 1.01
  • Material agreement signed Item 1.01
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed Item 1.01
  • Material agreement signed Item 1.01
  • Material agreement signed Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $9.44B 39.9x 3.1%
BCPC BALCHEM CORP $5.64B 37.3x 8.8%
PRM Perimeter Solutions, Inc. $4.55B — 16.4%
IOSP INNOSPEC INC. $2.43B 21.1x -3.7%
NGVT Ingevity Corp $2.39B — -2.7%
CC Chemours Co $1.93B — 0.4%
OLN OLIN Corp $1.78B — 3.7%
HUN Huntsman CORP $1.54B — -5.8%